Camp High 5: Evaluation of the Effect on Upper Limb Function
NCT ID: NCT02875054
Last Updated: 2017-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2016-06-30
2017-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arm More + Camp: An Implementation Study
NCT07065916
Constraint-induced Movement Therapy (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegic Cerebral Palsy
NCT00305006
Bimanual Training in Children With Hemiplegia
NCT01413594
Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia
NCT02918890
Constraint-induced Movement Therapy and Hand Arm Bimanual Training in Children With Hemiplegic Cerebral Palsy (CP)
NCT01078766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continued Casting
Participants with 24 hour cast wear (continued casting) for the entire duration of the constraint portion of camp (2 initial weeks).
Constraint induced movement therapy (CIMT)
Involves forcing use of ones affected upper extremity (UE) by physically restraining the less affected upper extremity
Hand-arm bimanual intensive training (HABIT)
Facilitates the translation of gains to improve goal-directed bimanual performance.
Intermittent Casting
Participants who wear a univalve cast for 3 hours of constraint camp with home exercise program of 2 hours cast wear on the weekends (intermittent casting).
Constraint induced movement therapy (CIMT)
Involves forcing use of ones affected upper extremity (UE) by physically restraining the less affected upper extremity
Hand-arm bimanual intensive training (HABIT)
Facilitates the translation of gains to improve goal-directed bimanual performance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Constraint induced movement therapy (CIMT)
Involves forcing use of ones affected upper extremity (UE) by physically restraining the less affected upper extremity
Hand-arm bimanual intensive training (HABIT)
Facilitates the translation of gains to improve goal-directed bimanual performance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Manual Ability Classification System or Mini Manual Ability Classification System classification I-III
Exclusion Criteria
* Inability to follow commands
* Family unable to commit to daily sessions for 4 weeks
* Unable to tolerate assigned casting protocol (3-24 hours) daily for 4 weeks
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renat Sukhov, MD
Role: PRINCIPAL_INVESTIGATOR
New York University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-00990
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.